88 filings
8-K
RGNX
Regenxbio Inc
11 Mar 24
REGENXBIO Announces Pricing of Upsized Public Offering of Common Stock and Pre-funded Warrants
8:00am
8-K
RGNX
Regenxbio Inc
27 Feb 24
REGENXBIO Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Operational Highlights
4:10pm
8-K
RGNX
Regenxbio Inc
8 Nov 23
REGENXBIO Announces Updated Strategic Plans and Third Quarter 2023 Financial Results
4:10pm
8-K
RGNX
Regenxbio Inc
1 Sep 23
Other Events
4:12pm
8-K
RGNX
Regenxbio Inc
2 Aug 23
REGENXBIO Reports Second Quarter 2023 Financial Results and Recent Operational Highlights
4:11pm
8-K
6hwsh98fw8nyw
5 Jun 23
Submission of Matters to a Vote of Security Holders
5:15pm
8-K
f2bd004879xccdd17wme
3 May 23
REGENXBIO Reports First Quarter 2023 Financial Results and Recent Operational Highlights
4:11pm
8-K
1r47qjrrm9o8f2leayps
28 Feb 23
REGENXBIO Reports Fourth Quarter 2022 and Full-Year 2022 Financial Results and Recent Operational Highlights
4:09pm
8-K
9naax2h7jez
10 Jan 23
Regenxbio Announces Senior Leadership Promotions
6:01am
8-K
fpwuhpor3tp30
3 Nov 22
REGENXBIO Reports Third Quarter 2022 Financial Results and Recent Operational Highlights
7:30am
8-K
wx1vi9 ita
3 Aug 22
REGENXBIO Reports Second Quarter 2022 Financial Results and Recent Operational Highlights
4:06pm
8-K
nvwxurc wo5
7 Jun 22
Jennifer Zachary Joins REGENXBIO Board of Directors
7:17am
8-K
exh7dp1
4 May 22
REGENXBIO Reports First Quarter 2022 Financial Results and Recent Operational Highlights
4:12pm
8-K
356r4yuqux pk
25 Mar 22
Entry into a Material Definitive Agreement
4:51pm
8-K
n7v760bkp0do5
18 Mar 22
Departure of Directors or Certain Officers
5:01pm
8-K
h8uegdbtwebfa 9a
1 Mar 22
REGENXBIO Reports Fourth Quarter and Full-Year 2021 Financial Results and Recent Operational Highlights
12:00am
8-K
cygwxa94
14 Feb 22
Regulation FD Disclosure
7:08am
8-K
lvrpgyzx
9 Feb 22
RGX-121, a one-time gene therapy for MPS II, continues to be well-tolerated with no drug-related SAEs across three dose levels
11:41am
8-K
ux7i 024vjv9eno2
15 Nov 21
Entry into a Material Definitive Agreement
7:52am
8-K
apwsmzho7vk if4
12 Nov 21
Regulation FD Disclosure
4:38pm